PFE dividend yield: 6.77%. KMB dividend yield: 4.00%. Pfizer offers one of the highest dividend yields among blue-chip pharma companies. Post-COVID revenue normalization has pressured earnings, but the dividend has been maintained. Pfizer's acquisition of Seagen adds oncology depth. With 14+ consecutive years of no dividend cuts, income investors see the high yield as an opportunity. KMB is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in KMB shares.
Pfizer offers one of the highest dividend yields among blue-chip pharma companies. Post-COVID revenue normalization has pressured earnings, but the dividend has been maintained. Pfizer's acquisition of Seagen adds oncology depth. With 14+ consecutive years of no dividend cuts, income investors see the high yield as an opportunity.
KMB is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in KMB shares.
PFE currently offers a 6.77% yield (1.68/share/year) while KMB offers 4.00% (2.00/share/year). PFE provides higher current income. However, KMB has grown its dividend faster (5% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in PFE vs KMB earn per year?
With $10,000 invested today: PFE pays approximately $677/year. KMB pays approximately $400/year. With DRIP reinvestment over 10 years, these grow to $5,820/year (PFE) and $899/year (KMB).
Does PFE or KMB pay monthly dividends?
PFE pays quarterly dividends. KMB pays quarterly dividends. Neither pay monthly — both use a quarterly schedule, which is preferred by investors who need regular cash flow.
📬
Get this PFE vs KMB comparison by email
Save your analysis + get weekly dividend insights. Free forever.